Amifostine in Treating Patients With Ovarian Epithelial Cancer Who Are Receiving Chemotherapy
Status:
Completed
Trial end date:
2003-01-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die. Chemoprotective drugs such as amifostine may protect normal cells
from the side effects of chemotherapy.
PURPOSE: Randomized phase III trial to study the effectiveness of amifostine in treating
patients who have ovarian epithelial cancer and who are receiving chemotherapy.